{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:10Z","timestamp":1791923590654,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.schres.2023.03.032","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:03:55Z","timestamp":1680120235000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations"],"prefix":"10.1016","volume":"268","author":[{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9lia","family":"Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.03.032_bb0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1176\/ajp.152.4.648","article-title":"Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate","volume":"152","author":"Adityanjee","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/JCP.0000000000001086","article-title":"A case report atypical neuroleptic malignant syndrome on clozapine and mood stabilizers","volume":"39","author":"Amador","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajp.2018.07.005","article-title":"Clozapine and lithium as maintenance therapy in a young treatment-resistant bipolar patient","volume":"36","author":"Amerio","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2023.03.032_bb0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11126-014-9291-9","article-title":"Rechallenging clozapine after neuroleptic malignant syndrome","volume":"85","author":"Anbalagan","year":"2014","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.schres.2023.03.032_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2045125315624063","article-title":"Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports","volume":"6","author":"Aydin","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.03.032_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jamapsychiatry.2016.3866","article-title":"Increasing the use of lithium and clozapine in US suicide prevention","volume":"74","author":"Bastiampillai","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S1461145703003870","article-title":"Safety and efficacy of combined clozapine-lithium pharmacotherapy","volume":"7","author":"Bender","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004714-199208000-00025","article-title":"Reversible neurologic symptoms with clozapine and lithium","volume":"12","author":"Blake","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004850-199805000-00008","article-title":"Lithium and clozapine-induced neutropenia\/agranulocytosis","volume":"13","author":"Blier","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0060","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.18l02282","article-title":"Mask Off? Lithium augmentation for clozapine rechallenge after neutropenia or agranulocytosis: discontinuation might be risky","volume":"20","author":"Boazak","year":"2018","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0000000000000478","article-title":"Clozapine underutilization in the treatment of schizophrenia: how can clozapine prescription rates be Improved?","volume":"36","author":"Bogers","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230109147387","article-title":"Initiation of clozapine therapy in a patient with preexisting leukopenia: a discussion of the rationale of current treatment options","volume":"13","author":"Boshes","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2009.01.024","article-title":"Use of lithium in the adult populations of Denmark, Norway and Sweden","volume":"118","author":"Bramness","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S0924933800002947","article-title":"Clinical observation of 11 patients under clozapine-lithium association","volume":"8","author":"Bryois","year":"1993","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0085","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1528-1167.2006.00861.x","article-title":"Electrolytes disturbances and seizures","volume":"47","author":"Castilla-Guerra","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.schres.2023.03.032_bb0090","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2215\/CJN.10021014","article-title":"Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"10","author":"Decker","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.schres.2023.03.032_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0000000000001042","article-title":"Clozapine-associated kidney injury complicated by lithium toxicity: a case report and literature review","volume":"39","author":"DeLucia","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15622975.2018.1500030","article-title":"Seizure rates under treatment with antipsychotic drugs: data from the AMSP project","volume":"20","author":"Druschky","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0115","article-title":"Long-term treatment of clozapine-induced leukopenia with lithium: fast-onset agranulocytosis following lithium discontinuation","volume":"18","author":"Dumas","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0120","first-page":"74","article-title":"Late-onset clozapine-induced neutropenia treated with lithium","volume":"32","author":"Durmus","year":"2019","journal-title":"Dusunen Adam-J.Psychiatry Neurol.Sci."},{"key":"10.1016\/j.schres.2023.03.032_bb0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17512433.2020.1787831","article-title":"Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"13","author":"de Filippis","year":"2020","journal-title":"Exp. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/bjpo.bp.116.003467","article-title":"Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia","volume":"3","author":"Foster","year":"2017","journal-title":"BJPsych Open"},{"key":"10.1016\/j.schres.2023.03.032_bb0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004714-199412000-00012","article-title":"Unsuccessful reexposure to clozapine","volume":"14","author":"Frankenburg","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/cap.2009.0012","article-title":"Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium","volume":"19","author":"Gagliano","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0145","first-page":"426","article-title":"Seizures in two patients after the addition of lithium to a clozapine regimen","volume":"14","author":"Garcia","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0150","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.chi.0000171904.23947.54","article-title":"Hematological adverse events in clozapine-treated children and adolescents","volume":"44","author":"Gerbino-Rosen","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0140-6736(91)90410-Q","article-title":"Polypharmacy in fatal clozapine-associated agranulocytosis","volume":"338","author":"Gerson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.03.032_bb0160","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2008.07111823","article-title":"Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia","volume":"165","author":"Ghaznavi","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/acps.13406","article-title":"Recognition and management of clozapine adverse effects: a systematic review and qualitative synthesis","volume":"145","author":"Gurrera","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamapsychiatry.2016.0432","article-title":"Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment: a UK population-based electronic health records study","volume":"73","author":"Hayes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0278-5846(95)00289-8","article-title":"Acute brain syndrome after tapering off clozapine in clozapine-lithium combination","volume":"20","author":"Hellwig","year":"1996","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0180","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v67n0509","article-title":"Lithium and clozapine rechallenge: a retrospective case analysis","volume":"67","author":"Kanaan","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11126-006-7963-9","article-title":"Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia","volume":"77","author":"Kelly","year":"2006","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.schres.2023.03.032_bb0190","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/npr2.12143","article-title":"Clozapine-associated severe eosinophilia following lithium rebound neutropenia: a case report","volume":"40","author":"Kikuchi","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.schres.2023.03.032_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102652","article-title":"Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia","volume":"60","author":"Kitagawa","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2023.03.032_bb0200","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1176\/ajp.151.10.1520b","article-title":"Diabetic ketoacidosis associated with clozapine treatment","volume":"151","author":"Koval","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0205","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2146\/ajhp060319","article-title":"Clozapine-induced leukopenia successfully treated with lithium","volume":"64","author":"Kutscher","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.schres.2023.03.032_bb0210","first-page":"184","article-title":"Reversible neurotoxicity induced by a combination of clozapine and lithium: a case report","volume":"62","author":"Lee","year":"1999","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.schres.2023.03.032_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/14740338.2.3.233","article-title":"Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings","volume":"2","author":"Lee","year":"2003","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.schres.2023.03.032_bb0220","first-page":"127","article-title":"Myoclonus during treatment with clozapine and lithium: the role of serotonin","volume":"11","author":"Lemus","year":"1989","journal-title":"Hillside J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0225","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen. Psychiatr."},{"key":"10.1016\/j.schres.2023.03.032_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0235","article-title":"Lithium for schizophrenia","volume":"2015","author":"Leucht","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2023.03.032_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bdi.12272","article-title":"Clozapine for treatment-resistant bipolar disorder: a systematic review","volume":"17","author":"Li","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0245","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/NDT.S270596","article-title":"Effects of lithium combined with second-generation antipsychotics for the treatment of manic episodes in patients with bipolar disorder: a naturalistic study in China","volume":"16","author":"Liu","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2023.03.032_bb0250","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1440-1614.2001.t01-3-01030.x","article-title":"Lithium induced raised intracranial pressure","volume":"36","author":"Mackirdy","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/cap.2011.0136","article-title":"Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia","volume":"23","author":"Maher","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2019.06.025","article-title":"A case of clozapine induced agranulocytosis 25 years after starting treatment: effective use of lithium for augmentation in rechallenge","volume":"210","author":"Martina","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0270","doi-asserted-by":"crossref","first-page":"425","DOI":"10.17161\/kjm.vol15.18501","article-title":"Do two rights make a Wrong? A case report on reversible neurotoxicity induced by coadministration of clozapine and lithium","volume":"15","author":"Masolak","year":"2022","journal-title":"Kans. J. Med."},{"key":"10.1016\/j.schres.2023.03.032_bb0275","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2019.1702","article-title":"Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies","volume":"76","author":"Masuda","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0280","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hup.1056","article-title":"Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children","volume":"24","author":"Mattai","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0285","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.03.032_bb0290","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/1039856219866361","article-title":"Therapeutic drug monitoring (TDM) during maintenance phase treatment at a community mental health centre","volume":"27","author":"Meehan","year":"2019","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0300","doi-asserted-by":"crossref","first-page":"e1410","DOI":"10.4088\/JCP.14m09326","article-title":"Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis","volume":"76","author":"Meyer","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0305","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0924-9338(98)80027-8","article-title":"Combined clozapine-lithium treatment for schizophrenia and schizoaffective disorder","volume":"13","author":"Moldavsky","year":"1998","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0315","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0004867417720516","article-title":"Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: a systematic review of the literature and clinical recommendations","volume":"51","author":"Myles","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/S0007125000296931","article-title":"Clinical management of clozapine patients in relation to efficacy and side-effects","author":"Naber","year":"1992","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2023.03.032_bb0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2023.03.032_bb0330","article-title":"Clozapine re-exposure after dilated cardiomyopathy","volume":"2017","author":"Nederlof","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.schres.2023.03.032_bb0335","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.17r02225","article-title":"Lithium neurotoxicity due to second-generation antipsychotics combined with lithium: a systematic review","volume":"21","author":"Netto","year":"2019","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0340","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.2011.01710.x","article-title":"Optimizing clozapine treatment","volume":"123","author":"Nielsen","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0345","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3371\/CSRP.4.2.5","article-title":"Lithium to allow clozapine prescribing in benign ethnic neutropenia","volume":"4","author":"Nykiel","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2023.03.032_bb0350","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/schbul\/sbab006","article-title":"There is life after the UK clozapine central non-rechallenge database","volume":"47","author":"Oloyede","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.03.032_bb0355","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602200066X","article-title":"Clozapine haematological monitoring for neutropenia: a global perspective","volume":"31","author":"Oloyede","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2023.03.032_bb0360","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S2215-0366(22)00188-2","article-title":"Relaxation of the criteria for entry to the UK clozapine central non-rechallenge database: a modelling study","volume":"9","author":"Oloyede","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0365","article-title":"Late-onset neutropenia in long-term clozapine use and its management utilizing prophylactic G-CSF","volume":"2021","author":"O'Neill","year":"2021","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0370","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/0269881116652577","article-title":"Lithium intoxication: incidence, clinical course and renal function - a population-based retrospective cohort study","volume":"30","author":"Ott","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0375","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2023.03.032_bb0380","article-title":"Leukocytosis associated with clozapine treatment: a case series and systematic review of the literature","volume":"57","author":"Paribello","year":"2021","journal-title":"Medicina-Lithuania"},{"key":"10.1016\/j.schres.2023.03.032_bb0385","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1176\/ajp.153.5.737b","article-title":"Diabetic ketoacidosis from clozapine and lithium cotreatment","volume":"153","author":"Peterson","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/JCP.0b013e3181d47b74","article-title":"Case report of long-term lithium for treatment and prevention of clozapine-induced neutropenia in an African American male","volume":"30","author":"Pinninti","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0395","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00005053-198608000-00010","article-title":"Apparent neuroleptic malignant syndrome with clozapine and lithium","volume":"174","author":"Pope","year":"1986","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2023.03.032_bb0400","first-page":"7359095","article-title":"Clozapine-induced microseizures, orofacial dyskinesia, and speech dysfluency in an adolescent with treatment resistant early onset schizophrenia on concurrent lithium therapy","volume":"2017","author":"Rachamallu","year":"2017","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2788.2006.00865.x","article-title":"Prevention of clozapine-induced granulocytopenia\/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia","volume":"51","author":"Rajagopal","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0410","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13651500903402450","article-title":"Incidence and risk for neutropenia\/agranulocytosis among clozapine users: a retrospective cohort study","volume":"14","author":"Ratanajamit","year":"2010","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.schres.2023.03.032_bb0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00002826-199619040-00008","article-title":"Asterixis induced by psychotropic drug treatment","volume":"19","author":"Rittmannsberger","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/acps.12827","article-title":"Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study","volume":"137","author":"Rohde","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17512433.2021.1877135","article-title":"An update on the complex relationship between clozapine and pneumonia","volume":"14","author":"Schoretsanitis","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12888-020-02592-2","article-title":"Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide","volume":"20","author":"Silva","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0435","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211015070","article-title":"Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital","volume":"11","author":"Silva","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0445","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0004867418772351","article-title":"Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis","volume":"52","author":"Siskind","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0450","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.jcp.0000084026.22282.5f","article-title":"Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder","volume":"23","author":"Small","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0455","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2017.16050542","article-title":"Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder","volume":"174","author":"Song","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0460","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/104454603322572697","article-title":"Clozapine-induced neutropenia in children: management with lithium carbonate","volume":"13","author":"Sporn","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","article-title":"Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia","volume":"173","author":"Stroup","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.032_bb0470","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/1756-0500-7-635","article-title":"Use of lithium in clozapine-induced neutropenia: a case report","volume":"7","author":"Suraweera","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.schres.2023.03.032_bb0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/schbul\/sbaa111","article-title":"Comparative effectiveness of antipsychotics for risk of attempted or completed suicide among persons with schizophrenia","volume":"47","author":"Taipale","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.03.032_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-247734","article-title":"Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels","volume":"15","author":"Takanobu","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.schres.2023.03.032_bb0485","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-019-00485-z","article-title":"Drug-induced intracranial hypertension: a systematic review and critical assessment of drug-induced causes","volume":"21","author":"Tan","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.schres.2023.03.032_bb0490","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.03.032_bb0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40345-019-0151-2","article-title":"Clinical use of lithium salts: guide for users and prescribers","volume":"7","author":"Tondo","year":"2019","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.schres.2023.03.032_bb0500","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/JCP.0b013e3181accfc3","article-title":"Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium","volume":"29","author":"Tseng","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0505","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-199300810-00011","article-title":"Clozapine-lithium combined treatment and agranulocytosis","volume":"8","author":"Valevski","year":"1993","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0510","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/acps.12344","article-title":"Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample","volume":"130","author":"Verdoux","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0515","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/acps.13172","article-title":"Educational needs and psychoeducation interventions in clozapine users: a narrative review","volume":"142","author":"Verdoux","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0520","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/acps.12554","article-title":"Geographical disparities in prescription practices of lithium and clozapine: a community-based study","volume":"133","author":"Verdoux","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: a systematic review","volume":"201","author":"Verdoux","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.03.032_bb0535","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14740338.2021.1912011","article-title":"A reappraisal of the role of fever in the occurrence of neurological sequelae following lithium intoxication: a systematic review","volume":"20","author":"Verdoux","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.schres.2023.03.032_bb0540","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/acps.13398","article-title":"Risk factors for clozapine-induced myocarditis and cardiomyopathy: a systematic review and meta-analysis","volume":"145","author":"Vickers","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.032_bb0545","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/15563650.2016.1185110","article-title":"Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome","volume":"54","author":"Vodovar","year":"2016","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.schres.2023.03.032_bb0550","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/bcp.14087","article-title":"Assessment of extracorporeal treatments in poisoning criteria for the decision of extracorporeal toxin removal in lithium poisoning","volume":"86","author":"Vodovar","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.03.032_bb0555","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00023210-200721010-00003","article-title":"Restarting clozapine after neutropenia - evaluating the possibilities and practicalities","volume":"21","author":"Whiskey","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2023.03.032_bb0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pnp.427","article-title":"Clozapine-induced neutropenia reversed by lithium","volume":"20","author":"Yadav","year":"2016","journal-title":"Prog. Neurol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:41:52Z","timestamp":1718106112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":112,"alternative-id":["S0920996423001263"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.03.032","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}